(Q43242859)

17 November 2017

Acute and chronic renal effects of guanfacine in essential and renal hypertension (English)

1 reference

17 November 2017

Roeckel A

1

1 reference

17 November 2017

Heidland A 2nd

series ordinal

2

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 January 1980

1 reference

British Journal of Clinical Pharmacology

17 November 2017

1 reference

17 November 2017

10 Suppl 1

1 reference

17 November 2017

141S-149S

1 reference

Acute hypotensive action of 2-(2,6-dichlorophenylamino)- 2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery

17 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430127

Localization of the central cardiovascular action of clonidine

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430127

Relationship of sodium retention produced by catapres to changes in renal hemodynamics.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430127

Guanfacinum (BS 100-14) in long-term therapy of severe hypertension

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430127

Pharmacology of BS 100-141, a centrally acting antihypertensive drug

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430127

Effects of clonidine and BS 100–141 on the EEG sleep pattern in rats

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430127

Acute effects of clonidine on central and peripheral haemodynamics and plasma renin activity

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1430127

Clinical and clinical-experimental studies with a new blood pressure lowering substance: dichlorophenylaminoimidazoline

25 May 2018

1 reference

12 December 2020

Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan)

1 reference

12 December 2020

[Experimental study of kidney hemodynamics and the behavior of electrolytes after a single administration of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride]

1 reference

12 December 2020

The acute effect of ST-155 hypotensive agent, on cardiac and renal hemodynamics

1 reference

12 December 2020

Evidence for direct alpha-adrenoceptor stimulation of effector neurons in cardiovascular centers by clonidine

1 reference

12 December 2020

Substituted phenylacetylguanidines: a new class of antihypertensive agents

1 reference

12 December 2020

The effect of clonidine on renin-release (author's transl)

1 reference

12 December 2020

First experiences with BS 100-141, a new antihypertensive substance

1 reference

12 December 2020

10.1111/J.1365-2125.1980.TB04922.X

Identifiers

DOI

1 reference

17 November 2017

1 reference

17 November 2017

PubMed publication ID

6994769

1 reference